There is limited knowledge on the use of individual care plans (ICPs) in primary care and the effects of ICPs on the quality of care.

-   ICP use among chronically ill patients within primary care in the Netherlands is low (less than 10% reported having an ICP in 2011).

-   Findings suggest that ICPs are more often employed for patients who have a less favourable social background and health.

-   Patients with an ICP more often feel that the delivered care is structured according to the principles of the Chronic Care Model, compared with patients without an ICP.

Introduction {#S0002}
============

Several countries have introduced individual care plans (ICPs) in chronic illness care \[[@C1]\]. ICPs are intended to help provide chronically ill patients with proactive, holistic, coordinated care that is tailored to their needs and preferences \[[@C7]\]. The starting points of ICPs are the goals that patients and their healthcare provider(s) mutually agree on. Healthcare providers coach patients on achieving these goals and support patients' self-management. Working with ICPs is expected to improve the quality of chronic illness care, which will subsequently lead to improved health outcomes and quality of life, and reduced healthcare utilization \[[@C7]\].

In the Netherlands, ICPs were introduced as part of the chronic disease management approach that was adopted for several chronic diseases within primary care \[[@C3]\]. Disease management was first introduced for patients with diabetes mellitus (2007), and at a later stage for patients with cardiovascular disease as well as those with a high risk of developing cardiovascular disease (2009) and patients with COPD (2010). In 2012, the Dutch Health Care Inspectorate concluded that ICPs were still hardly used by diabetes care groups within primary care \[[@C8]\]. This conclusion is in line with other (small-scale) studies, which estimate that no more than 10% of Dutch patients with diabetes mellitus type 2 had an ICP \[[@C9],[@C10]\]. There are signs to indicate that the level of ICP implementation is also low in Norway and the United Kingdom \[[@C2],[@C11]\].

Studies (mostly qualitative studies) have identified a complex set of barriers and facilitators related to the organization of healthcare, and characteristics of healthcare providers and patients \[[@C11]\]. Recent research among four diabetes care groups (109 general practitioners \[GPs\]) in the Netherlands showed that GPs especially consider a patient\'s older age and lack of skills when it comes to discouraging ICP use, in addition to a lack of time on their part \[[@C9]\]. This suggests that ICPs are less often employed for more vulnerable patients. However, in England Burt and colleagues found that more vulnerable patients, i.e. patients living in deprived areas and patients reporting poor health, more often had an ICP \[[@C11]\].

The study by Burt et al. showed positive relationships between patients' reporting of ICPs and better perceived access, continuity of care, and interpersonal care \[[@C11]\]. However, until now there has been only limited quantitative evidence that using ICPs could improve the quality of chronic illness care.

To increase our knowledge of ICP use in primary care, the present study aimed to:

1.  provide a picture of the nationwide level of ICP implementation in primary chronic illness care in the Netherlands;

2.  gain insight into patient characteristics related to ICP use;

3.  explore the relationship between (patient-reported) ICP use and patient-perceived quality of chronic illness care.

Material and methods {#S0003}
====================

Sample {#S0004}
------

A nationwide sample of adult, non-institutionalized patients with somatic chronic disease(s) was derived from a prospective panel-study in the Netherlands \[[@C15]\]. Each year panel members are recruited from (random samples of) general practices throughout the country, via a standardized procedure (see \[[@C15]\] for a description of this procedure). Panel members participate in two or three surveys a year, for a maximum of four years. Survey topics are self-rated health, use of healthcare, perceived quality of care, and quality of life. The panel-study is registered with the Dutch Data Protection Authority; all data are collected and handled according to the privacy protection guidelines of the Authority.

In April 2011, the panel consisted of 1669 patients diagnosed with all types of somatic chronic disease(s), recruited in 2007 to 2010. Of this sample 1377 persons filled in either a postal (n = 1336) or internet (n = 41) questionnaire (response rate 83%). Additionally 225 of 259 COPD patients, who had been recruited from general practices from 2007 till early in 2011 via the same standardized procedure for a disease-specific study, participated in the same survey (response rate 87%). Hence, the total group of participants for this study comprised 1602 chronically ill patients derived from 82 general practices ([Figure 1](#F1){ref-type="fig"}).

![Flowchart study sample.](ipri-33-100.01){#F1}

Data {#S0005}
----

*Outcome measures.* Patients indicated whether or not they had an ICP for the management of their chronic disease(s): yes/no. The question was preceded by a short explanation of what is meant by the term ICP.

The Patient Assessment of Chronic Illness Care questionnaire (PACIC) \[[@C16]\] was included to assess the extent to which patients receive care that aligns with the Chronic Care Model (CCM) \[[@C17]\]. The PACIC distinguishes five dimensions of chronic illness care: patient activation, delivery system design/decision support, goal setting, problem-solving/contextual counselling, follow-up/coordination. The 20 items are scored on a five-point scale, from 1 (never) to 5 (always). Scale scores (total and subscales) are computed by averaging the items completed within the (sub)scale. Missing values are replaced by the respondent\'s mean value of the other items belonging to the (sub)scale, in the case where the respondent filled in at least 50% of the items of a (sub)scale. High scores indicate that the delivered care is perceived as structured according to the principles of the CCM from the patient\'s perspective.

*Patient characteristics.* Socio-demographic characteristics included gender, age, and educational level. Patients' self-reported educational level reflected the highest level of education completed and was classified as low (no, primary, or lower vocational education), intermediate (secondary or intermediate vocational education) and high (higher vocational education or university).

Health literacy was assessed using a brief screening instrument \[[@C18]\], containing three questions: "How often do you have someone help you read materials from your hospital, GP or other health care institutions?", "How confident are you filling out medical forms by yourself?", and 'How often do you have problems learning about your medical condition because of difficulty understanding written information?" These items are scored on a five-point scale (0--4). The scale score is computed by averaging the items within the scale. Missing values are replaced by the sample\'s mean value of the item, in the case of respondents having only one of the three items missing. A score of ≤ 2 indicates inadequate health literacy.

GPs provided data on the chronic disease(s) diagnosed (coded according to the International Classification of Primary Care \[[@C19]\]). Based on these data, we computed the number of chronic diseases per patient.

Self-rated health was based on the first item of the RAND-36: "In general, would you say your health is: 1 = excellent, 2 = very good, 3 = good, 4 = fair, 5 = poor" \[[@C20],[@C21]\].

*Statistical analyses.* Statistical analyses were performed in Stata^™^ version 12 (StataCorp, College Station, TX, USA) \[[@C22]\]. To assess the level of implementation of ICPs, percentages and 95% confidence intervals of patients reporting an ICP among the generic sample were computed. In addition, percentages of patients reporting an ICP were calculated for different diagnostic groups and for patients with one chronic disease or with multimorbidity (i.e. being diagnosed with two or more chronic diseases).

To assess whether certain patient characteristics were associated with ICP use, multi-level logistic regression analysis \[[@C23]\] was conducted with data from the total sample. Two models were estimated: a null model taking into account the variance in ICP use between general practices (random part) and a main model in which several patient characteristics (age, educational level, health literacy, type and number of chronic diseases, self-rated health) were added to the fixed part of the model. For the variables in the fixed part, odds ratios with 95% confidence intervals are presented. For the random part, the variance at GP level with the standard error is presented.

To explore the relationship between (patient-reported) ICP use and PACIC scores, two-sample t-tests were conducted with data from the total sample.

Results {#S0006}
=======

Sample characteristics {#S0007}
----------------------

Characteristics of the generic sample of patients with a chronic illness and of the extra sample of COPD patients are outlined in [Table I](#TB1){ref-type="table"}.

###### 

Characteristics of the generic sample of patients with chronic somatic illness (n = 1377) and the extra sample of patients diagnosed with COPD (n = 225).

  -----------------------------------------------------------------------------------------------------------
                                            Generic sample   Additional sample of COPD patients         
  ----------------------------------------- ---------------- ------------------------------------ ----- -----
  Patient characteristics:                                                                              

  Gender                                                                                                

   Male                                     632              46                                   131   58

   Female                                   745              54                                   94    42

  Age:                                                                                                  

   15--39 years                             69               5                                    0     0

   40--64 years                             639              46                                   91    40

   65--74 years                             383              28                                   79    35

   ≥ 75 years                               286              21                                   55    25

  Educational level:                                                                                    

   Low                                      489              36                                   119   53

   Intermediate                             549              41                                   71    32

   High\                                    309              23                                   33    15
  Health literacy:^1^                                                                                   

   Inadequate                               102              8                                    20    9

   Adequate                                 1229             92                                   195   91

  Type of chronic disease diagnosed:^2^                                                                 

   Asthma                                   159              12                                   20    9

   COPD                                     146              11                                   225   100

   Other chronic respiratory disease        70               5                                    5     2

   Cardiovascular disease/high risk         403              29                                   51    23

   Arthritis                                219              16                                   11    5

   Other chronic musculoskeletal disorder   136              10                                   7     3

   Cancer                                   132              10                                   5     2

   Diabetes mellitus                        332              24                                   21    9

   Thyroid dysfunction                      115              8                                    7     3

   Migraine                                 63               5                                    1     0

   Neurological disease                     78               6                                    3     1

   Chronic digestive disorder               91               7                                    8     4

   Chronic skin disease                     113              8                                    4     2

   Other chronic disease                    225              16                                   15    7

  Number of chronic diseases diagnosed:                                                                 

   One                                      714              52                                   113   50

   Two                                      397              29                                   72    32

   Three or more                            266              19                                   40    18

  Self-rated general health:                                                                            

   Excellent                                29               2                                    2     1

   Very good                                136              10                                   11    5

   Good                                     735              54                                   111   49

   Fair                                     424              31                                   85    38

   Poor                                     45               3                                    16    7
  -----------------------------------------------------------------------------------------------------------

Notes: ^1^Cronbach\'s alpha was 0.72, indicating good internal consistency. ^2^Since a proportion of the patients had been diagnosed with more than one chronic disease, these percentages sum up to more than 100.

ICP use {#S0008}
-------

Of the total generic sample answering the question (n = 1234), 9% (95% CI 7--10) reported having an ICP. The use of ICPs among different diagnostic groups varied between 4% (patients with migraine) and 14% (patients with neurological diseases). Among diagnostic groups for which disease management programmes had been developed (before 2011), the proportions of patients reporting an ICP were 13% (diabetes, COPD) and 9% (cardiovascular disease/high risk). Of the patients diagnosed with one chronic disease 8% had an ICP; among those with multimorbidity the figure was 11%.

Patient characteristics associated with ICP use {#S0009}
-----------------------------------------------

[Table II](#TB2){ref-type="table"}, model 1 shows that some patient characteristics significantly relate to ICP use. Patients diagnosed with COPD, diabetes mellitus, or another (unspecified) chronic disease are more likely to have an ICP. Furthermore, patients with a low level of education (compared with patients with a high level of education) and patients with poor(er) self-rated health are more likely to have an ICP.

###### 

Multilevel logistic regression models to estimate ICP use among chronically ill patients within general practice (n = 1371).

                                                                            Model 0   Model 1                  
  ------------------------------------------------------------------------- --------- ------------------------ ------
  Fixed part                                                                          OR (95% CI)              SE
  Age, years (ref. 15--64 years):                                                                              
   65--74 years                                                                       0.84 (0.54--1.31)        0.19
   ≥ 75 years                                                                         0.86 (0.52--1.41)        0.22
  Educational level (ref. = low):                                                                              
   Intermediate                                                                       1.20 (0.80--1.81)        0.25
   High                                                                               0.50 (0.27--0.94)\*      0.16
  Health literacy: adequate (ref. = inadequate)                                       0.66 (0.37--1.17)        0.19
  Type of chronic disease diagnosed (ref. = absence of specific disease):                                      
   Asthma                                                                             0.95 (0.47--1.89)        0.33
   COPD                                                                               1.74 (1.01--2.98)\*      0.48
   Other chronic respiratory disease                                                  1.39 (0.54--3.54)        0.66
   Cardiovascular disease / high risk                                                 1.05 (0.61--1.80)        0.29
   Arthritis                                                                          0.97 (0.52--1.82)        0.31
   Other chronic musculoskeletal disorder                                             1.42 (0.72--2.80)        0.49
   Cancer                                                                             1.01 (0.47--2.18)        0.40
   Diabetes mellitus                                                                  1.78 (1.06--2.98)\*      0.47
   Thyroid dysfunction                                                                1.12 (0.54--2.35)        0.42
   Migraine                                                                           0.43 (0.10--1.86)        0.32
   Neurological disease                                                               1.76 (0.81--3.84)        0.70
   Chronic digestive disorder                                                         1.18 (0.50--2.78)        0.52
   Chronic skin disease                                                               0.79 (0.31--1.98)        0.37
   Other chronic disease                                                              1.81 (1.05--3.14)\*      0.51
  Multimorbidity present (ref. = absent)                                              0.88 (0.47--1.64)        0.28
  Self-rated general health (ref. = excellent--very good)                                                      
   Good                                                                               4.16 (1.28--13.58)\*     2.51
   Fair--poor                                                                         5.51 (1.67--18.15)\*\*   3.35

  Random part                     Estimate   SE     Estimate   SE
  ------------------------------- ---------- ------ ---------- ------
  Variance between GP practices   0.06       0.10   0.00       0.00

Notes: Significance levels: \*p \< 0.05; \*\* p \< 0.01. OR = odds ratio; CI = confidence interval; SE = standard error.

Relationship between ICP use and perceived quality of care {#S0010}
----------------------------------------------------------

Perceived quality of care was assessed with the PACIC. Cronbach\'s alpha for the total PACIC scale and the subscales in this study indicated good internal consistency ([Table III](#TB3){ref-type="table"}). Significant differences exist between patients with and without an ICP regarding their PACIC scores (total scale and all five subscales; [Table III](#TB3){ref-type="table"}), indicating that patients with an ICP more often have the experience that the care they receive is patient-centred, proactive, planned, and includes collaborative goal setting, problem-solving, and follow-up support than patients without an ICP.

###### 

Mean PACIC scores of patients with and without an ICP and results of Student\'s t-tests for independent samples.

                                            α      Patients with ICP   Patients without ICP   t             df    p                   
  ----------------------------------------- ------ ------------------- ---------------------- ------------- ----- --------- --------- ----------
  PACIC total score                         0.93   2.67 (1.00)         116                    1.94 (0.74)   741   --7.636   135.75    \< 0.001
  Patient activation                        0.83   3.33 (1.39)         120                    2.76 (1.38)   764   --4.210   882       \< 0.001
  Delivery system design/decision support   0.68   3.19 (1.17)         120                    2.60 (1.06)   757   --5.622   875       \< 0.001
  Goal setting                              0.81   2.53 (1.15)         116                    1.81 (0.91)   733   --6.474   138.968   \< 0.001
  Problem-solving/contextual counselling    0.93   2.85 (1.33)         113                    1.75 (1.05)   713   --8.331   135.206   \< 0.001
  Follow-up/coordination                    0.73   1.78 (0.91)         110                    1.36 (0.57)   735   --4.626   122.437   \< 0.001

Notes: M = mean; SD = standard deviation; t = t-value; df = degrees of freedom; p = significance level.

Discussion {#S0011}
==========

The present study provides evidence that ICP use among chronically ill primary care patients in the Netherlands is low (9% in 2011). Patients with a low educational level and patients with poor(er) self-rated health were more likely to have an ICP. Responses from patients with an ICP showed that they more often feel that the provided care corresponds to the principles of the Chronic Care Model, compared with patients without an ICP.

Strengths and weaknesses {#S0012}
------------------------

Data for this study were derived from a nationwide sample of patients diagnosed with chronic disease(s) in the Netherlands, which provides the opportunity to generalize our findings regarding ICP use to the Dutch population of non-institutionalized (somatic) chronically ill patients. It should, however, be noted that our findings were based on patients' self- report. Patients might have misinterpreted the concept of ICP, which could have led to both under- and over-reporting. We tried to avoid misinterpretation by providing a short explanation in the questionnaire of what an ICP is or could look like. Nevertheless, some misunderstanding might have occurred.

Another issue is the cross-sectional design of the study, which does not allow causal interpretation. This means that our findings could indicate that the use of an ICP results in a perception of receiving chronic illness care of a higher quality, but it may also be the other way round. Moreover, there may be factors that lead people to report the use of an ICP, which may also increase the likelihood of people reporting that they have received higher quality chronic illness care. For instance, it is known that patients with a low educational level are generally more positive about the quality of the care they receive than patients with a high educational level \[[@C24],[@C25]\], and in our study patients with a low level of education also more often reported the use of an ICP. On the other hand, it is also well known that patients with poor (self-rated) health are generally less positive about the care they receive than patients with better (self-rated) health \[[@C24],[@C25]\], but in our study patients who rated their health more poorly reported using an ICP more frequently -- instead of less frequently -- than patients with better self-rated health. The latter finding strengthened our belief that asking patients to report the use of a (concrete) ICP does not evoke an entirely subjective answer that reflects their perception of the quality of care. Nevertheless, it is recommended that future research also makes use of other data sources concerning the use of ICPs (i.e. medical files, reports by healthcare professionals).

Discussion of main findings {#S0013}
---------------------------

Less than 10% of the total generic sample reported having an ICP in April 2011. This result is in line with findings from a study in the United Kingdom, where the National Health Service determined in 2008 that all people with one or more long-term conditions should be offered an ICP within two years \[[@C1]\]. Data from the 2009/2010 General Practice Patient Survey in England showed that only 12% of patients with a long-term condition reported having an ICP \[[@C11]\]. A low implementation level was also found in Norway, where ICPs were introduced in 2001 for patients with long-term and complex needs for coordinated care. Despite legal obligations and national initiatives by health authorities, five years after the introduction the use of ICPs was still low, particularly among general practitioners (GPs) \[[@C2]\].

Diagnostic groups for which disease management programmes have been developed in the Netherlands (before 2011) seem to have a slightly higher chance of having an ICP, though evidence for this was found only among diabetes and COPD patients and not among patients with (an increased risk of) cardiovascular disease, for which a disease management approach was also adopted. Even among patients with diabetes or COPD the proportions reporting an ICP were still low (13%), which supports the findings of previous studies that ICP use within diabetes care -- which is considered a forerunner of the disease management approach in the Netherlands -- lags behind policy aspirations. In England, where ICPs are also considered an important component of good diabetes care (according to standards of care), it was estimated that only one-third of all diabetic patients had an ICP in 2011 \[[@C26]\].

Current ICP use within primary care in the Netherlands seems to depend, to some extent, on the complexity of a patient\'s situation: patients with a low level of education and/or poor(er) self-rated health were more likely to report having an ICP. These findings suggest that ICPs are more often employed for patients who have a less favourable social background and health. This is in line with the findings of Burt et al. showing that ICPs are more often reported by patients living in areas of deprivation and patients reporting poorer health \[[@C11]\].

Burt and colleagues concluded that the low level of implementation might reflect uncertainty as to the benefits of ICPs \[[@C11]\]. This might also hold for the Dutch situation: in a previous study we found that both diabetes care providers and type 2 diabetics are not yet convinced of the benefits of ICP use \[[@C9]\]. The present study explored the association between ICP use and patients' experiences with the quality of chronic illness care. The findings indicate that patients with an ICP more often feel that the care they receive is patient-centred, proactive, planned, and includes collaborative goal setting, problem-solving, and follow-up support, compared with patients without an ICP. These findings are in line with results recently published by Reeves et al., showing a positive relationship between the PACIC total score and ICP use among patients with long-term conditions in the UK \[[@C27]\].

We conclude that ICP use among chronically ill patients within primary care in the Netherlands is low, even among diagnostic groups for which a nationwide disease-management approach was adopted. This implies that there is a gap between practice and policy aspirations to implement ICPs in primary chronic illness care.

Implications for practice and research {#S0014}
--------------------------------------

The present study provides evidence that, to some extent, patient characteristics relate to patients' chances of having an ICP. The question arises as to whether ICPs should be provided to patients in less favourable (health or social) conditions only, or be employed for all chronically ill patients. Knowing that chronic illness demands a proactive approach from patients and healthcare providers to prevent or postpone complications and to maintain the best possible quality of life, it seems undesirable to make such selections based on patient characteristics. Coulter and colleagues also stress that -- in contrast to other models -- the care planning model encompasses all people with long-term conditions, not just those in high-risk groups \[[@C7]\]. Future research should gain more insight into which approach is preferable.

More knowledge is needed concerning factors that facilitate or impede the implementation of ICPs in chronic illness care, on the level of the patient but also on the level of healthcare providers and organizations (e.g. attitude, time investment, supportive environments). Moreover, while interventions to address the burden of chronic disease should be evidence-based, and use scientifically sound evaluation methods that are practicable in routine settings \[[@C28]\], there is still only limited evidence regarding the (cost-)effectiveness of individualized care planning. Research is urgently needed to gain insight into the (cost-)effectiveness of ICP use in various patient populations within chronic illness care. Such studies should be conducted within the complex setting of day-to-day healthcare, in order to gain a realistic view of contextual evidence \[[@C29]\].
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